Geospatial disparities in pediatric heart failure care in China: a multicenter cohort study

Muhammad Junaid Akram1,2, Yin Yue1,2, Asad Nawaz1,2

  • 1Department of Cardiology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China.

PubMed

Insights

Geographic location significantly impacts pediatric heart failure (PHF) survival in China. Children in Western and Central regions face higher mortality risks due to disparities in care and disease presentation.

Area of Science:

  • Cardiology
  • Public Health
  • Geospatial Analysis

Background:

  • Pediatric heart failure (PHF) presents unique challenges distinct from adult heart failure.
  • Significant geospatial healthcare disparities exist in China, impacting PHF patient outcomes.
  • The influence of these disparities on PHF patient profiles, management, and survival was unquantified.

Purpose of the Study:

  • To systematically examine the association between geographic location and PHF patient profiles.
  • To analyze the impact of geographic location on PHF management and survival outcomes.
  • To quantify the effect of geospatial healthcare disparities on pediatric heart failure in China.

Main Methods:

  • Retrospective analysis of 2,903 pediatric inpatients with primary HF diagnosis (2013-2022).
  • Geospatial stratification into Eastern, Western, and Central China cohorts.
  • Multivariable logistic regression for in-hospital mortality, adjusted for confounders; Gamma generalized linear model for length of stay.

Main Results:

  • Western patients were younger with higher congenital heart disease prevalence and severe clinical status.
  • Cardiomyopathy dominated in the East; guideline-directed medical therapy (GDMT) was lowest in non-Eastern regions.
  • Geographic region independently predicted mortality: adjusted odds of death 2.58x higher in West, 3.54x higher in Central China compared to East.

Conclusions:

  • Geographic location is a significant independent predictor of survival for pediatric heart failure patients in China.
  • Findings reveal a tiered healthcare landscape with urgent need for interventions.
  • Targeted interventions are crucial to mitigate disparities and ensure equitable care through regional capacity building and standardized referral pathways.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319